Opus Genetics (IRD)
NASDAQ:IRD
Holding IRD?
Track your performance easily

Opus Genetics (IRD) Cash flow

989 Followers

Opus Genetics Cash Flow

IRD's free cash flow for Q2 2024 was $-7.29M. For the 2024 fiscal year, IRD's free cash flow was decreased by $-15.43M and operating cash flow was $-7.29M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -11.46M$ -1.11M$ 14.31M$ -19.37M$ -6.80M$ -3.59M
Investing Cash Flow
---$ -100.00K$ 539.00K$ -25.00K
Financing Cash Flow
$ 12.89M$ 8.98M$ 3.79M$ 27.61M$ 21.12M$ 4.70M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 189.10M$ 50.50M$ 42.63M$ 24.53M$ 16.40M$ 1.54M
Income Tax Paid Supplemental Data
$ 344.00K$ 344.00K--$ 0.00$ 0.00
Interest Paid Supplemental Data
--$ 9.00K$ 2.00K$ 0.00$ 0.00
Issuance Of Capital Stock
$ 13.27M$ 9.23M$ 4.43M$ 28.49M$ 21.15M$ 0.00
Issuance Of Debt
--$ -538.00K$ 538.00K$ 2.20M$ 4.71M
Repayment Of Debt
--$ -538.00K$ -108.00K$ 0.00-
Free Cash Flow
$ -11.46M$ -1.11M$ 14.31M$ -19.37M$ -6.80M$ -3.62M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Opus Genetics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis